Insider in COMP stock (NYSE: COMP) plans 4,749-share Rule 144 sale
Rhea-AI Filing Summary
A holder of COMP common stock filed a Form 144 notice to sell shares under Rule 144. The planned transaction covers 4,749 shares of common stock, with an aggregate market value of $63,304.17, to be sold through Morgan Stanley Smith Barney LLC on the NYSE around 01/26/2026. These shares were acquired on the same date via an exercise of stock options paid in cash.
The filing also lists prior sales under a Rule 10b5‑1 trading plan over the past three months, including 182,452 shares sold on 01/09/2026 for $2,422,827.47 and 197,568 shares sold on 01/07/2026 for $2,413,522.78, along with several smaller November 2025 sales. The signer represents they are not aware of undisclosed material adverse information about the issuer.
Positive
- None.
Negative
- None.
Insights
Form 144 details planned and recent Rule 10b5‑1 insider sales in COMP common stock.
The notice shows a planned sale of $63,304.17 in COMP common stock, representing 4,749 shares to be sold on the NYSE through Morgan Stanley Smith Barney LLC. These shares come from a same‑day stock option exercise funded with cash, a common structure for insiders to monetize equity compensation while maintaining clear documentation.
The filing also itemizes prior Rule 10b5‑1 sales over the last three months, including blocks of 182,452 and 197,568 shares sold in January 2026 for proceeds of $2,422,827.47 and $2,413,522.78, plus smaller sales in November 2025. Because these trades are under a pre‑arranged plan, they are generally viewed as more routine, and the signer affirms they are not aware of any undisclosed material adverse information. On its own, this activity is best interpreted as administrative disclosure of insider liquidity rather than a clear change in the company’s outlook.
FAQ
Which broker and exchange are involved in the COMP Form 144 sale?
The planned sale of COMP common stock is to be executed through Morgan Stanley Smith Barney LLC on the New York Stock Exchange (NYSE).
What recent 10b5-1 sales of COMP stock are disclosed in this filing?
The filing lists several Rule 10b5‑1 sales for Bradley Serwin, including 182,452 shares sold on 01/09/2026 for $2,422,827.47 and 197,568 shares sold on 01/07/2026 for $2,413,522.78, along with smaller sales in November 2025.
Does the COMP Form 144 state anything about undisclosed adverse information?
Yes. By signing the notice, the person for whose account the COMP securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.
What type of securities are involved in the COMP Form 144?
The Form 144 relates to common stock of the issuer listed as COMP, with trades executed on the NYSE.